Glenview Trust’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,418
Closed -$241K 465
2023
Q3
$241K Sell
1,418
-549
-28% -$109K 0.01% 408
2023
Q2
$439K Sell
1,967
-33
-2% -$6.75K 0.01% 337
2023
Q1
$442K Buy
2,000
+220
+12% +$54.2K 0.01% 332
2022
Q4
$386K Hold
1,780
0.01% 333
2022
Q3
$471K Sell
1,780
-150
-8% -$38.1K 0.02% 286
2022
Q2
$403K Buy
1,930
+100
+5% +$22.3K 0.01% 315
2022
Q1
$405K Buy
1,830
+180
+11% +$38K 0.01% 328
2021
Q4
$386K Hold
1,650
0.01% 331
2021
Q3
$361K Buy
+1,650
New +$352K 0.01% 316

Other funds holding ALB

Glenview Trust's ALB Position: Q4 2023 in Review

Glenview Trust sold out of Albemarle (ALB) in Q4 2023, closing a stake of 1,418 shares — an estimated $241K sold.

Glenview Trust first reported a position in ALB in Q3 2021 and held it in 9 quarters. The position peaked at $471K in Q3 2022. 940 funds tracked by Wall St. Rank hold ALB as of Q4 2023.

  • Glenview Trust reported no remaining Albemarle position as of Q4 2023 after selling out during the quarter.
  • Glenview Trust sold 1,418 Albemarle shares in Q4 2023, an estimated $241K.
  • Glenview Trust first reported a position in Albemarle in Q3 2021 and held it in 9 quarters.
  • Glenview Trust's Albemarle position peaked at $471K in Q3 2022.
  • 940 funds tracked by Wall St. Rank held Albemarle as of Q4 2023.

Based on Glenview Trust's 13F filing for Q4 2023, filed 12 Feb 2024.